Clinical application of diffusion tensor tractography in classification of pediatric optic chiasmatic gliomas: a retrospective cohort study - Takeaways - MDSpire

Clinical application of diffusion tensor tractography in classification of pediatric optic chiasmatic gliomas: a retrospective cohort study

  • By

  • Ping Yang

  • Yuting Liang

  • Jiashu Chen

  • Zhuo Zhi

  • Wei Yang

  • Jia Wang

  • Chen Liang

  • Xiaojiao Peng

  • Yingjie Cai

  • Yuanqi Ji

  • Wenping Ma

  • Ming Ge

  • June 3, 2026

  • 0 min

Share

  • 1

    The study evaluated the predictive value of diffusion tensor tractography (DTT) classification for pediatric optic chiasmatic gliomas (OCGs).

  • 2

    A total of 53 pediatric patients with OCGs were included, with clinical parameters collected for prognosis analysis over various time spans.

  • 3

    DTT classification identified three tumor types, with the inflating endophytic type linked to lower body weight and higher diencephalic syndrome prevalence.

  • 4

    Postoperative chemotherapy significantly improved overall survival and event-free survival in pediatric OCG patients.

  • 5

    DTT-based classification serves as a valuable tool for preoperative guidance and highlights the importance of combined adjuvant chemotherapy.

Original Source(s)

Clinical application of diffusion tensor tractography in classification of pediatric optic chiasmatic gliomas: a retrospective cohort study

  • by Ping Yang, Yuting Liang, Jiashu Chen, Zhuo Zhi, Wei Yang, Jia Wang, Chen Liang, Xiaojiao Peng, Yingjie Cai, Yuanqi Ji, Wenping Ma, Ming Ge

  • June 3, 2026

Related Content

Immune checkpoint inhibitor–related myocarditis in a patient with hepatocellular carcinoma: a case report

This Week’s Biopharma News: New Approvals, Appeals, and AI

Datroway and Hepcludex secure notable FDA approvals, while Outlook wins its bevacizumab appeal, BioMarin reports phase 3 VOXZOGO data, and BMS partners with Anthropic

  • June 2, 2026

  • 5 min
Case Report: Cytokeratin-positive interstitial reticulum cell tumor with HLA loss of heterozygosity